$4.55
0.112.48%
Last update: Nov 3, 6:59 PM
Prime Medicine Inc
PRMENASDAQ
Prime Medicine (PRME) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.25 | $-0.25 | $-0.25 | $-0.23 |
| Actual | $-0.24 | $-0.28 | $-0.24 | $-0.32 |
| Surprise | +4.00% | -12.0% | +4.00% | -39.1% |
| Revenue | ||||
| Estimate | $1.8M | $1.0M | $2.2M | $4.2M |
| Actual | $1.2M | $856000 | $838000 | $1.2M |
| Surprise | -34.6% | -16.0% | — | -71.2% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.23 | $-0.22 | $-0.21 | $-0.22 |
| Revenue | ||||
| Consensus | $2.0M | $7.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.24 | $-0.25 | 4.00 % |
| Q1 | May 7, 2026 | $-0.28 | $-0.25 | -12.0 % |
| Q4 | Mar 3, 2026 | $-0.24 | $-0.25 | 4.00 % |
| Q3 | Nov 7, 2025 | $-0.32 | $-0.23 | -39.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $1.15M | $1.76M | -34.6 % |
| Q1 | May 7, 2026 | $856.00K | $1.02M | -16.0 % |
| Q3 | Nov 7, 2025 | $1.23M | $4.25M | -71.2 % |
| Q2 | Aug 7, 2025 | $1.12M | $2.90M | -61.6 % |
